Iomeron (Iomeprol)

Iomeprol works by delivering a high concentration of iodine atoms into the targeted compartment. Iodine strongly absorbs X‑ray photons, increasing the radiodensity of the area where it is administered. This creates a pronounced contrast between the enhanced region and surrounding tissues, allowing radiologists to differentiate structures more clearly on X‑ray, CT or fluoroscopic images.

The dose of Iomeron is determined by the prescribing physician based on the specific imaging study, patient size, renal function and the route of administration. Clinicians calculate the appropriate volume and concentration required to achieve optimal contrast while minimizing exposure. Exact dosing regimens are not standardized and must follow the prescriber's order.

Safety data for Iomeron during pregnancy and lactation are limited. It should only be used when the diagnostic benefit outweighs potential risks to the fetus or infant. Healthcare providers typically avoid routine use in pregnant or nursing women unless essential, and they may consider alternative imaging modalities that do not require iodinated contrast.

To order Iomeron, submit an enquiry on the product page at gnhindia.com, specifying the required quantity. GNH India supplies hospitals, pharmacies and procurement teams across international markets. After receiving the request, the sales team will verify trade or institutional credentials, then provide pricing, availability, shipping details (including any cold‑chain requirements) and assist with import documentation.

Iomeron (Iomeprol) is comparable to other non‑ionic, low‑osmolality iodinated agents such as iohexol and iopamidol. All provide high‑quality X‑ray attenuation with a favorable safety profile. Differences may lie in specific iodine concentration, viscosity, and approved indications. Selection often depends on institutional preference, patient tolerance, and the imaging protocol required for a given procedure.

Iomeron should be stored at ambient temperature, below 25 °C, in its original sealed container. Protect the product from direct sunlight, moisture and extreme temperature fluctuations. Do not freeze or shake the vial. Follow standard aseptic handling procedures when preparing the solution for intra‑arterial, intra‑articular or intrathecal administration.

Iomeron is supplied as a sterile injectable solution and is administered by a qualified healthcare professional. Depending on the clinical need, it can be injected intra‑arterially for vascular imaging, intra‑articularly for joint studies, or intrathecally into the cerebrospinal fluid space. The administration technique follows standard radiology protocols and is performed under imaging guidance.

The most serious risks include severe allergic reactions such as anaphylaxis, acute kidney injury especially in patients with pre‑existing renal impairment, and rare neurological events like seizures. Cardiovascular complications such as hypotension, arrhythmias or myocardial infarction may also occur in high‑risk individuals. Prompt recognition and management of these events are essential.

Iomeron should be avoided in patients with a known severe hypersensitivity to iodinated contrast media, uncontrolled hyperthyroidism, or significant renal dysfunction where the risk of contrast‑induced nephropathy is high. It is also contraindicated in individuals who have had a recent reaction to a similar contrast agent or who are undergoing radioactive iodine therapy within a short interval.